Meet us at WSJ Health Forum

WSJ Health Forum

Join our CEO, Colin Hill with an influential community of scientists, business leaders, investors, policymakers and experts from across the sector to explore the trends, technologies, ideas and opportunities reshaping the business and science of health on Feb 21, 2024 in Boston at WSJ Forum. Find more details here.  

Meet us at J.P.Morgan Healthcare Conference

J.P. Morgan

As we prepare to wrap up another exciting year for Aitia, we’re eagerly looking forward to a bustling 2024. For now, we’re gearing up for the J.P. Morgan conference, where our CEO, Colin Hill and President, COO, Jean-Michel Gries will be in attendance. Be sure to connect with them and request a meeting through the […]

Prediction of Amyloid PET Positivity from Blood-Based Biomarkers, Proteomics, and Clinical Data Discovered through Aitia’s Digital Twins to be Presented at CTAD 2023

CTAD 2023 1

We are delighted to announce that Aitia will be at the Clinical Trials on Alzheimer’s Disease conference (CTAD) being held from October 24-27 in Boston, MA. We will be presenting a poster focused on prediction of Amyloid PET positivity of Alzheimer’s Disease (AD) through Gemini Digital Twins of AD patients, based on blood-based biomarkers and […]

A Digital Boost for Pharmaceutical R&D: Join our CEO, Colin Hill at the Orion Day in Finland

Orion Day

We are thrilled to announce that Aitia will be participating at the Orion Day conference. Our CEO, Colin Hill, will be giving a keynote titled:  AI-Powered Digital Twins: Revolutionizing Pharmaceutical Drug Discovery and Clinical Development to Create the Next Generation of Breakthrough Drugs. During the keynote, Colin will share valuable insights and engage in a dynamic […]